| Objectives:To study the effect of1,25(OH)2D3on mediating Abeta across the blood-brain barrier and its mechanism, we set up the model of blood-brain barrier by mouse brain micro vascular endothelial cells (bEnd.3). Methods:(1) MTT assay was used to find the non-cytotoxicity dosage of1,25(OH)2D3;the dosage at which the survival rate of cells is above90%was considered as the highest non-cytotoxicity dosage.(2)Using hypoxia to induce the abnormal expression of LRP1ã€BCRP and RAGE in the brain micro vascular endothelial cells, which would happen with pathological characteristics of Alzheimer’s disease.The expression of LRP1, BCRP, RAGE were analysed by real-time PCR and Western blot after giving1,25(OH)2D3(3) VDR mRNA and protein expression using real-time PCR and Western blot analysis.(4)Establish in vitro model to study the effect of1,25(OH)2D3on Abeta across the blood-brain barrier.Results:(1)We choose1nM,10nM,100nM for the next experiments by MTT assay.(2)The expression of LRP1and BCRP mRNA are decreased significantly, while the RAGE mRNA increases after hypoxia (P<0.05); After giving1,25(OH)2D3, the expression of LRP1mRNA was increased while RAGE mRNA was decreased in all groups (P<0.01).100nM1,25(OH)2D3could up regulate the level of BCRP mRNA (P<0.05). Hypoxia down-regulated the protein expression of LRP1and BCRP while increased RAGE expression (P<0.01) Given1,25(OH)2D3,medium and high dose groups (10nM and100nM) could up-regulate LRP1expression (P<0.01). There is no significant differences between1nM and hypoxia control. All1,25(OH)2D3groups could down-regulate the expression of RAGE (P<0.01); only100nM could increased BCRP expression (P<0.05).(3)1,25(OH)2D3could increased the expression of VDR at10nM and100nM significantly (P<0.05).(4)The result of A(3bidirectional transport assay has shown that the permeability was similar between the low dosage and the control (proximately4.3%), and ER was1.85with insignificant effect. While the medium and high dose groups could make the transport rate from BL to AP increased significantly (5.6%and6.2%respectively), and the efflux rates ER are2.62and3.23respectively. Conclusions:1,25(OH)2D3could increased the expression of Aβ efflux transporters BCRP and LRP1and decreased the influx receptor RAGE expression on blood brain barrier, which may increase the Abeta transport rate from BL-AP remarkably. The effect that1,25(OH)2D3affects on BCRPã€LRP1and RAGE may be realized via Vit D-VDR signaling pathway. |